Výsledky vyhledávání - "Rodney P. E. Pollard"

Towards personalised treatment in primary Sjogren's syndrome

Autor: Konstantina Delli, Rodney P. E. Pollard, Frans G. M. Kroese, Hendrika Bootsma, Stephan Ihrler, Bert van der Vegt, Arjan Vissink, Frederik Spijkervet, Erlin A. Haacke

Publikováno v: Annals of the Rheumatic Diseases, 75(11), 1933-1938. BMJ PUBLISHING GROUP

ObjectivesThe aims of this study were (1) to assess the effect of rituximab (RTX; anti-CD20) treatment in patients with primary Sjögren's syndrome (pSS) based on sequential parotid biopsies obtained in a placebo-controlled, randomised clinical trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5677100d3366cbacbac7b334746a30
https://hdl.handle.net/11370/1f749da5-a515-46b6-89e8-b11cf5c5f3f8

Zobrazit plný text záznamu

In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI

Autor: Rodney P. E. Pollard, Frans G. M. Kroese, Konstantina Delli, Arjan Vissink, Frederik Spijkervet, Hendrika Bootsma, Stephan Ihrler, Bert van der Vegt, Erlin A. Haacke

Publikováno v: Annals of the Rheumatic Diseases, 75(6):e34. BMJ PUBLISHING GROUP

With great interest we have read the letter to the editor by Cornec et al 1 regarding our paper ‘Towards personalised treatment in primary Sjogren's syndrome (pSS): baseline parotid histopathology predicts responsiveness to rituximab treatment’.2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0719265d024d4823e3bd460a92503d06
https://pubmed.ncbi.nlm.nih.gov/26895746

Zobrazit plný text záznamu

Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjogren's syndrome after B cell depletion therapy

Autor: Rodney P. E. Pollard, Frans G. M. Kroese, Erlin A. Haacke, Saravanan Yuvaraj, Fred K. L. Spijkervet, Annie Visser, Cees G. M. Kallenberg, Nicolaas A. Bos, Arjan Vissink, Nishath Hamza, Hendrika Bootsma

Publikováno v: Annals of the Rheumatic Diseases, 71(11), 1881-1887. BMJ PUBLISHING GROUP

ObjectivesTo assess the persistence of immunoglobulin-producing cell populations in the parotid salivary glands of patients with primary Sjögren's syndrome (pSS) after B cell depletion therapy with rituximab.MethodsThirteen patients with pSS and fou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10dc03680bc4c9a2d7c465a8c4bd18e
https://hdl.handle.net/11370/059d820b-8c9e-4f60-b9b6-15f986cc0cf5

Zobrazit plný text záznamu

Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome

Autor: Jan L. N. Roodenburg, Arjan Vissink, Philip M. Kluin, Fred K. L. Spijkervet, Gustaaf W. van Imhoff, Hendrika Bootsma, Rodney P. E. Pollard, Cees G. M. Kallenberg, J. Pijpe

Publikováno v: Journal of Rheumatology, 38(10), 2198-2208. J RHEUMATOL PUBL CO

Objective.To retrospectively analyze the clinical course of patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma of the parotid gland and associated Sjögren’s syndrome (SS).Methods.All consecutive patients with SS and MALT lymphoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff20cee14714d6d1c826211cdb709403
https://doi.org/10.3899/jrheum.110077

Zobrazit plný text záznamu

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome

Autor: Johannes G. M. Burgerhof, Annie Visser, Nishath Hamza, Cees G. M. Kallenberg, Wayel H. Abdulahad, Rodney P. E. Pollard, Frans G. M. Kroese, Minke G. Huitema, Hendrika Bootsma, Fred K. L. Spijkervet, Jiska Meijer, Arjan Vissink

Publikováno v: Annals of the Rheumatic Diseases, 72(1), 146-8. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 72(1), 146-148. BMJ PUBLISHING GROUP

B cell depletion therapy with rituximab (RTX; 2 weekly infusions of 1000 mg, premedication: 100 mg prednisolone) in primary Sjogren's syndrome (pSS) patients is effective in reducing subjective and objective symptoms.1 As B cell activating factor (BA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d81aa13e31b72a98e8a7cdeb8858fd
https://doi.org/10.1136/annrheumdis-2012-202071

Zobrazit plný text záznamu

Preclinical validation of salivary biomarkers for primary Sjögren's syndrome

Autor: Hui Zhou, Martha Arellano-Garcia, Lei Zhang, Arjan Vissink, Kai Gao, David Elashoff, David T.W. Wong, Shen Hu, Rodney P. E. Pollard, Cees G. M. Kallenberg

Publikováno v: ARTHRITIS CARE & RESEARCH, 62(11), 1633-1638. Wiley

Objective. Sjogren's syndrome (SS) is a systemic autoimmune disease with a variety of presenting symptoms that may delay its diagnosis. We previously discovered a number of candidate salivary biomarkers for primary SS using both mass spectrometry and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632b3d44bfaffc986451c2139e81c0b3
https://pubmed.ncbi.nlm.nih.gov/20617533

Zobrazit plný text záznamu

Towards personalized treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment

Autor: S. Ihrler, Arjan Vissink, Konstantina Delli, Erlin A. Haacke, Rodney P. E. Pollard, Franciscus Kroese, Frederik Spijkervet, Hendrika Bootsma

Publikováno v: International Journal of Oral and Maxillofacial Surgery. 44:e147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d54df03e79319ab97ed0362077284b3d
https://doi.org/10.1016/j.ijom.2015.08.814

Zobrazit plný text záznamu

SAT0190 Reduction of serum immunoglobulin free light chains upon rituximab (anti-CD20) treatment correlates with decreased disease activity in patients with primary sjögren’s syndrome

Autor: D. M. Bruining, Rada V Moerman, H. J. Burgerhof, Johannes G. M. Burgerhof, Petra M. Meiners, Franciscus Kroese, Jiska Meijer, Rodney P. E. Pollard, Hendrika Bootsma, Arjan Vissink

Publikováno v: Annals of the Rheumatic Diseases. 71:535.3-536

Background Immunoglobulin free light chains (FLCs) are short-lived products of B lymphocytes and possess a wide range of immunological properties as signaling effectors or anti-inflammatory molecules. There is an upcoming interest in the role of circ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c9c6a9feb79032441ac1a70d43c1647
https://doi.org/10.1136/annrheumdis-2012-eular.3137

Zobrazit plný text záznamu

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model

Autor: Hui Zhou, David T.W. Wong, Franciscus Kroese, Sara A. Michie, Rodney P. E. Pollard, Ammon B. Peck, Chaochao Cai, Hendrika Bootsma, Sven U. Gorr, Arjan Vissink, Cornelis Kallenberg, Frederik Spijkervet, Steve Horvath, Abu N. M. Nazmul-Hossain

Publikováno v: Arthritis Research and Therapy, 14(6):238. BioMed Central Ltd.
Arthritis Research & Therapy
Horvath, Steve; Nazmul-Hossain, Abu NM; Pollard, Rodney PE; Kroese, Frans GM; Vissink, Arjan; Kallenberg, Cees GM; et al.(2012). Systems analysis of primary Sjogren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Research & Therapy, 14(6), R238. doi: http://dx.doi.org/10.1186/ar4081. Retrieved from: http://www.escholarship.org/uc/item/1gc1p0nd

Introduction: Primary Sjogren's syndrome (pSS) is a chronic autoimmune disease with complex etiopathogenesis. Despite extensive studies to understand the disease process utilizing human and mouse models, the intersection between these species remains

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d516b7de6d78c77384e42e2f846769
https://doi.org/10.1186/ar4081

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání